<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-130082</identifier>
<setSpec>0009-739X</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Autoimmune pancreatitis: a surgical dilemma</dc:title>
<dc:description xml:lang="en">Autoimmune pancreatitis (AIP) is defined as a particular form of pancreatitis that often manifests as obstructive jaundice associated with a pancreatic mass or an obstructive bile duct lesion, and that has an excellent response to corticosteroid treatment. The prevalence of AIP worldwide is unknown, and it is considered as a rare entity. The clinical and radiological presentation of AIP can mimic bilio-pancreatic cancer, presenting difficulties for diagnosis and obliging the surgeon to balance decision-making between the potential risk presented by the misdiagnosis of a deadly disease against the desire to avoid unnecessary major surgery for a disease that responds effectively to corticosteroid treatment. In this review we detail the current and critical points for the diagnosis, classification and treatment for AIP, with a special emphasis on surgical series and the methods to differentiate between this pathology and bilio-pancreatic cancer (AU)</dc:description>
<dc:creator>Vaquero, Eva C</dc:creator>
<dc:creator>Saavedra-Perez, David</dc:creator>
<dc:creator>Fernandez-Cruz, Laureano</dc:creator>
<dc:creator>Ayuso, Juan R</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La pancreatitis autoinmune (PAI) es una enfermedad fibroinflamatoria benigna del páncreas, se manifiesta frecuentemente como ictericia obstructiva asociada a masa pancreática o lesión obstructiva de la vía biliar y presenta una respuesta excelente a corticoides. Aunque no existen estudios a nivel mundial que definan su epidemiología, la PAI se considera una entidad poco frecuente, con una prevalencia estimada del 2% de los pacientes con pancreatitis crónica. Su frecuente presentación clínica y radiológica en forma de masa pancreática e ictericia similar al cáncer de páncreas y la falta de elementos diagnósticos específicos son causa de un elevado porcentaje de resecciones quirúrgicas pancreáticas por una enfermedad benigna que responde a tratamiento médico. En esta revisión detallamos los acuerdos actuales para el diagnóstico, clasificación y tratamiento de la PAI, enfatizando en las series quirúrgicas y en estrategias para mejorar el diagnóstico diferencial con el cáncer de páncreas y evitar así resecciones pancreáticas innecesarias (AU)</dc:description>
<dc:source>Cir. Esp. (Ed. impr.);92(10): 645-653, dic. 2014. tab, ilus</dc:source>
<dc:identifier>ibc-130082</dc:identifier>
<dc:title xml:lang="es">Pancreatitis autoinmune: un dilema quirúrgico</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d10378^s22009</dc:subject>
<dc:subject>^d23188^s22074</dc:subject>
<dc:subject>^d10382^s22009</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d10367^s29166</dc:subject>
<dc:subject>^d10378^s22080</dc:subject>
<dc:subject>^d22935</dc:subject>
<dc:subject>^d23405</dc:subject>
<dc:subject>^d50479^s22080</dc:subject>
<dc:subject>^d13732^s22080</dc:subject>
<dc:subject>^d23188^s22045</dc:subject>
<dc:subject>^d10367^s22053</dc:subject>
<dc:subject>^d24529^s22031</dc:subject>
<dc:subject>^d10382^s22080</dc:subject>
<dc:subject>^d10371^s22053</dc:subject>
<dc:subject>^d10371^s29166</dc:subject>
<dc:type>article</dc:type>
<dc:date>201412</dc:date>
</metadata>
</record>
</ibecs-document>
